Author:
Nieminen M. M.,Hill M.,Irvin C. G.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference38 articles.
1. J. T. O'Flaherty, R. L. Wykle, C. H. Mille, J. C. Lewis, M. Waite, D. A. Bass, C. E. McCall and L. R. DeChatelet,1-0-alkyl-sn-glyceryl-3-phosphorylcholines: A novel class of neutrophil stimulants. Am J. Pathol.103, 70–78 (1981).
2. A. J. Wardlaw, R. Moqbel, O. Cromwell and A. B. Kay,Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest.78, 1701–1706 (1986).
3. B. B. Vargaftig, J. Lefort, M. Chignard and J. Benveniste,Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivates. Eur. J. Pharmacol.65, 185–192 (1980).
4. M. Halonen, J. D. Palmer, I. C. Lohman, L. M. McManus and R. N. Pinckard,Respiratory and circulatory alterations induced by acetylglyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am. Rev. Respir. Dis.122, 915–924 (1980).
5. O. Gateau, B. Arnoux, H. Deriz, P. Viars and J. Benveniste,Acute effects of intratracheal administration of PAF-acether (platelet-activating factor) in humans. Am. Rev. Respir. Dis129, A3 (1984).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献